Adverse effects of GLP – 1 Receptor Agonists
Introduction and purpose Glucagon-like peptide-1 receptor agonists (GLP – 1 RAs) are indicated in type 2 diabetes (T2D) and obesity because of their high efficacy in controlling blood glucose levels and inducing weight loss. Patients may develop gastrointestinal adverse effects (GI AEs) such as nau...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Kazimierz Wielki University
2025-02-01
|
| Reeks: | Journal of Education, Health and Sport |
| Onderwerpen: | |
| Online toegang: | https://apcz.umk.pl/JEHS/article/view/57774 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|